CompoAtlas

BED TIME HOT CHOCOLATE

Food supplement declared in France, declaration No 2023-6-1542

BED TIME HOT CHOCOLATE (HSN) is a food supplement declared in France. Status: retrait du marché annoncé pour le 11 June 2028. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
HSN
Food business operator placing the product on the market
HARRISON SPORT NUTRITION, S.L.
Status
Retrait du marché annoncé pour le 11 June 2028
Form
Poudre
Daily dose
2 doseurs (20g)
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous antidépresseurs, Sous traitement médicamenteux, Enfants (de moins de 6 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil
Flavourings
CHOCOLAT

Declaration 244784, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Griffonia simplicifolia (DC.) Baill.GraineExtrait sec hydroalcoolique200 mg

Other active ingredients

NamePer day
Glycinenot declared
Tryptophanenot declared
Acide gamma-aminobutyriquenot declared
Théaninenot declared
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Sels de magnésium de l'acide citriqueMagnésium250 mg300 mg
Chlorure de sodiumSodiumpas de limite (données insuffisantes)aucune dose fixée
Citrate de zincZinc25 mg15 mg

Additives

E501, E525, E415, E955

Other ingredients

lait, poudre de cacao

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé chez les personnes sous traitement antidépresseur, les personnes souffrant de maladies inflammatoires ou auto-immunes, ainsi que les femmes enceintes et allaitantes, les enfants et les adolescents, et toute personne exerçant une activité nécessitant une vigilance soutenue où la somnolence pourrait poser un problème de sécurité. Les personnes épileptiques, asthmatiques, souffrant de troubles de l'humeur, du comportement ou de la personnalité, ou sous traitement médicamenteux, doivent demander l'avis d'un professionnel de santé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : HSN

Enter to analyse, Shift+Enter for a new line